RecruitingNot ApplicableNCT07088900

The Effectiveness of Dexmedetomidine as an Adjuvant for Bupivacaine Caudal Block in Pediatric Open Appendectomy Under General Anesthesia


Sponsor

Ain Shams University

Enrollment

60 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate if adding dexmedetomidine to bupivacaine in a caudal block can provide longer and better quality pain relief for children after open appendectomy surgery. The study will also assess the effect of this combination on the quality of recovery, including the incidence of emergence delirium, and its overall safety profile.


Eligibility

Min Age: 2 YearsMax Age: 7 Years

Inclusion Criteria1

  • ASA (American Society of Anesthesiologists) physical status I or II.

Exclusion Criteria8

  • Refusal of participation by the legal guardian.
  • Known allergy or hypersensitivity to local anesthetics or dexmedetomidine.
  • Coagulation disorder or receiving anticoagulant therapy.
  • Active infection at or near the injection site.
  • Significant anatomical abnormalities of the lumbosacral spine.
  • Pre-existing neurological disorders, psychiatric disorders, or a history of convulsions.
  • Anticipated surgery time of more than 2.5 hours.
  • Patients with severe asthma or active wheezing.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREcaudal block using dexmedetomidine with bupivacaine

Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 µg/kg of dexmedetomidine (diluted in 1 mL of normal saline).

PROCEDUREcaudal block with bupivacaine

Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 mL of normal saline


Locations(1)

Ain Shams university hospitals

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07088900


Related Trials